Timothy M. Shannon, Director at CytomX Therapeutics, Inc. (CTMX), sold 94,154 shares at $10.08 ($948K) on 2016-06-08, disclosed to the SEC on 2016-06-10.
Open-market sale of $948k CTMX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.08 | 22,885 | $231K | 24.3% |
| 2 | $10.08 | 22,885 | $231K | 24.3% |
| 3 | $10.06 | 22,842 | $230K | 24.2% |
| 4 | $10.06 | 22,842 | $230K | 24.2% |
| 5 | $10.01 | 2,700 | $27K | 2.9% |
| Total | $10.07 avg | 94,154 |
| $948K |
| 100% |
| Filing → |
| ARVN | SELL | 2021-09-27 | $4.3M | — | Filing → |
| ARVN | SELL | 2021-09-27 | $32.9M | — | Filing → |
| RLYB | BUY | 2021-08-04 | $1000K | — | Filing → |